Sitemap

Posts

• The Team Approach
• Staying Knowledgeable About FDA Changes
• A Fight We’re Eager to Engage In
• Outside Focus & Inner Wellness
• Event: FDA Regulatory Strategies and CMC Considerations
• How New Drugs Are Made
• Taking a breather with our new Be Healthy Club
• Proprietary Liposomal Formulation Platform Technology Partnership Opportunity
• China’s CROs Make Connection in S.D.
• Getting Children What They Deserve
• The Yakatan Rules for Pharma R&D Efficiency #1
• Z-Endoxifen manufactured for the National Cancer Institute
• The Yakatan Rules for Pharma R&D Efficiency #2
• San Diego Food Bank Initiative – Food 4 Kids Backpack Program
• Poor solubility and rapid degradation in acidic environments
• Are you new to the concept of Current Good Manufacturing Practices (cGMPs)?

Pages

• About Us
  • Leadership
  • Our Culture
  • Job Posts
  • Case Studies
• Contact Us
• Home
• Newsroom
• Blog
• GMP Manufacturing
  • Clinical Supply Manufacturing
  • Specialty Commercial Manufacturing
• Formulation Technologies
  • Difficult to Develop Products
  • Novel Drug Delivery Technologies
  • Analytical Support
• Strategic Consulting
  • Pre-IND Meetings with FDA
  • IND & ANDA Filings
  • FDA Regulatory Strategies
  • Phase 1 & 2 Protocol Design and CRO Management
  • International Company Assistance
• Terms and Conditions
• Privacy Policy

Press Releases

• IRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million
• IRISYS Expands Management Team, Appoints Hwa-Chang (Lawrence) Wang Director of Manufacturing
• IRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference
• IRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder
• IRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference
• IRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference
• IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme
• IRISYS Exhibits at Inaugural CPhI North America Conference
• IRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value
• IRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.
• IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum
• IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development
• IRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials
• IRISYS Receives MetroConnect Award & California Competes Tax Credit

Team

• Jin Jean Wang, Ph.D.
• Gerald J. Yakatan, Ph.D.
• Robert Giannini, Ph.D.
• Louis Scotti
• Victoria Smith Karpinski
• Igor Nikoulin, Ph.D.
• Kevin Xie
• Brooke Yakatan